News from other websites on Cadila Healthcare
Expect two more novel drugs by 2020: Zydus Cadila
Jun 09, 2013 at 18:47 | Source: The Hindu BusinessLine
New Delhi, June 9: Buoyed by approval for its patented diabetes drug Lipaglyn, Zydus Cadila today said it expects at least two molecules out of the 20 currently under discovery research programmes to become successful by 2020.The firm, which has set...
Myanmar allows access to Indian airlines
Jun 09, 2013 at 15:56 | Source: Economic Times
YANGON: Indian airlines can now operate flights to Myanmar as the country has granted traffic rights to India-based carriers paving the way for air connectivity between the nations. "Yes, we (Indian airlines) got the fifth freedom rights which is a ...
India seeks wider access to Myanmar banking sector
Jun 06, 2013 at 23:13 | Source: The Hindu BusinessLine
Nay Pyi Taw (Myanmar), June 6: India has sought wider access to Myanmar’s energy and banking sectors as the two countries targeted doubling two-way trade to $3 billion in the next two years. Public sector bank United Bank of India has set up a...
Cadila launches India's first new drug
Jun 06, 2013 at 13:50 | Source: DNA India
Cadila Healthcare has announced the launch of the first new chemical entity (NCE) developed by an Indian pharmaceutical company Lipaglyn a drug that will help in lowering cholesterol in diabetic patients and in glycemic control. The company expects ...
Cadila gets approval to market new diabetes drug Lipaglyn in India
Jun 06, 2013 at 13:04 | Source: FirstPost
Mumbai: Drugmaker Cadila Healthcare Ltdreceived regulatory approval to market a new diabetes drug in India that it developed and is aiming for more than $1 billion in sales globally, the company said on Wednesday.Cadila, India's sixth-largest drugmak...
Cadila launches IndiaâÂÂs first new drug
Jun 06, 2013 at 09:20 | Source: DNA India
Cadila Healthcare has announced the launch of the first new chemical entity (NCE) developed by an Indian pharmaceutical company Lipaglyn a drug that will help in lowering cholesterol in diabetic patients and in glycemic control. The company expects ...
Jun 06, 2013 at 04:37 | Source: Calcutta Telegraph News
Mumbai, June 5: Cadila Healthcare will launch a homegrown drug against diabetes by the third quarter of this year. The Drug Controller General of India has approved its drug — Lipaglyn — to treat “diabetic dyslipidemia”. Diab...
Sensex snaps losing streak; foreign flows a worry
Jun 06, 2013 at 01:30 | Source: FirstPost
MUMBAI (Reuters) - The BSE Sensex gained on Wednesday after three days of falls as Sun Pharmaceutical Industries(SUN.NS) rose after Sweden's Meda(MEDAa.ST) denied it was in talks to sell itself, while Larsen & Toubro(LART.NS) advanced after winni...
Cadila Healthcare aims at over $1B annual global revenues from breakthrough <b>...</b>
Jun 05, 2013 at 20:00 | Source: VC Circle
Ahmedabad-based Cadila Healthcare Ltd said on Wednesday it has got approval from the Indian drug regulator Drug Controller General of India (DGCI) to launch what it claimed is the first indigenously developed new chemical entity (NCE) Lipaglyn, which...
Sensex slips as weak macro data dampens mood; Titan dn 3%
Jun 05, 2013 at 19:02 | Source: DomainB
Benchmark indices ended lower in volatile trade Tuesday, as a steady stream of weak macro-economic data kept buyers on the back foot. A 50-month low reading of HSBC Manufacturing Purchasing Managers' index for May is the latest indicator that a reco...
RIL rally helps Sensex close up; Just Dial up 15% on debut
Jun 05, 2013 at 19:02 | Source: DomainB
Benchmark indices closed slightly up Wednesday, lifted by a 2.6 percent surge in Reliance Industries shares ahead of the company's annual general meeting Thursday. Just Dial, which debuted on the exchange today, was the star performer of the day, ri...
Cadila health to market new diabetes drug in India
Jun 05, 2013 at 16:00 | Source: NDTV Profit
Mumbai: Drugmaker Cadila Healthcare Ltd received regulatory approval to market a new diabetes drug in India that it developed and is aiming for more than $1 billion in sales globally, the company said on Wednesday. Cadila, India's sixth-large...
Cadila Healthcare gets approval to market new diabetes drug in India
Jun 05, 2013 at 14:46 | Source: FirstPost
Mumbai: Drugmaker Cadila Healthcare Ltdreceived regulatory approval to market a new diabetes drug in India that it developed and is aiming for more than $1 billion in sales globally, the company said on Wednesday.Cadila, India's sixth-largest drugmak...
Nifty struggles at 5900, realty biggest loser, Maruti top gainer
Jun 05, 2013 at 09:24 | Source: FirstPost
The Indian markets again opened weak this morning with the Sensex down 20 points at 19495 and the Nifty trading just above the 5900 trading mark.The global cues are subdued. US indices ended in the red. Asian stocks are lower. Fears that the Fed will...
Pharma stocks gain on value-buying
Jun 05, 2013 at 05:00 | Source: FirstPost
Reuters Market Eye - Shares in pharmaceutical companies are leading the gains on Tuesday due to factors such as value-buying and expectations that promoters may increase stake in some companies, dealers say.Ranbaxy Laboratories Ltd (RANB.NS) gains 4....
Sensex slips to one-month closing low; caution seen as FIIs sell index futures
Jun 05, 2013 at 02:15 | Source: FirstPost
MUMBAI (Reuters) - The BSE Sensex fell for a third consecutive session on Tuesday to its lowest close in a month after lenders such as State Bank of India dropped on continued uncertainty over rate cuts and on caution as foreign investors sold index ...
Sensex ends up ahead of Q4 GDP data; Tata Motors, M&M lead
May 30, 2013 at 20:12 | Source: DomainB
Equity benchmarks finished higher Thursday after trading in a narrow range for most part of the day. Dealers attributed the late spike to squaring of short positions in the derivatives segment, today being the settlement day for May series. The BSE ...
Cadila's Q4 profit up 53.59 per cent to Rs 262.46 crore
May 30, 2013 at 17:30 | Source: Economic Times
NEW DELHI: Drug maker Cadila Healthcare on Thursday reported 53.59 per cent rise in consolidated net profit at Rs 262.46 crore for the fourth quarter ended March 31. The company had posted a consolidated net profit of Rs 170.88 crore in same quarter ...
Query Corner: Bombay Dyeing hovering above key support
May 25, 2013 at 21:32 | Source: The Hindu BusinessLine
What is your advice regarding medium- and long-term outlook on Wockhardt and Cadila Healthcare? Can these stocks be bought at the current levels? Anil Kumar Ray Wockhardt (Rs 1,229.7): This stock has received a sharp cut since May 15, making the sto...
Pharma's defensive tag comes under threat; regulatory patent tiffs up sector s risk profile
May 25, 2013 at 04:31 | Source: Economic Times
The recent regulatory lapses surrounding Indian pharmaceutical companies have raised concerns regarding the defensiveness of the sector when pitted against other defensive industries like the fast moving consumer goods (FMCG). Defensiveness is the a...
From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'
